Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 31

1.

Glucose Metabolism Changes in Patients with Chronic Hepatitis C Treated with Direct Acting Antivirals.

Drazilova S, Janicko M, Skladany L, Kristian P, Oltman M, Szantova M, Krkoska D, Mazuchova E, Piesecka L, Vahalova V, Rac M, Schreter I, Virag L, Koller T, Liptakova A, Ondrasova M, Jarcuska P.

Can J Gastroenterol Hepatol. 2018 Oct 3;2018:6095097. doi: 10.1155/2018/6095097. eCollection 2018.

2.

Chronic Hepatitis C Association with Diabetes Mellitus and Cardiovascular Risk in the Era of DAA Therapy.

Drazilova S, Gazda J, Janicko M, Jarcuska P.

Can J Gastroenterol Hepatol. 2018 Aug 13;2018:6150861. doi: 10.1155/2018/6150861. eCollection 2018. Review.

3.

Serum Uric Acid in Roma and Non-Roma-Its Correlation with Metabolic Syndrome and Other Variables.

Petrikova J, Janicko M, Fedacko J, Drazilova S, Madarasova Geckova A, Marekova M, Pella D, Jarcuska P.

Int J Environ Res Public Health. 2018 Jul 4;15(7). pii: E1412. doi: 10.3390/ijerph15071412.

4.

Prevalence and Risk Factors for Hepatitis B Virus Infection in Roma and Non-Roma People in Slovakia.

Drazilova S, Janicko M, Kristian P, Schreter I, Halanova M, Urbancikova I, Madarasova-Geckova A, Marekova M, Pella D, Jarcuska P; HepaMeta Team.

Int J Environ Res Public Health. 2018 May 22;15(5). pii: E1047. doi: 10.3390/ijerph15051047.

5.

Seroprevalence of Hepatitis E Virus in Roma Settlements: A Comparison with the General Population in Slovakia.

Halánová M, Veseliny E, Kalinová Z, Jarčuška P, Janičko M, Urbančíková I, Pella D, Dražilová S, Babinská I; HepaMeta Team.

Int J Environ Res Public Health. 2018 May 3;15(5). pii: E904. doi: 10.3390/ijerph15050904.

6.

Global prevalence, treatment, and prevention of hepatitis B virus infection in 2016: a modelling study.

Polaris Observatory Collaborators.

Lancet Gastroenterol Hepatol. 2018 Jun;3(6):383-403. doi: 10.1016/S2468-1253(18)30056-6. Epub 2018 Mar 27. Review.

PMID:
29599078
7.

The Impact of Selected Groups of Non-communicable Disease Deaths on Life Expectancy in the Slovak Republic.

Gavurová B, Vagašová T, Dražilová S, Jarčuška P.

Cent Eur J Public Health. 2017 Dec;25 Suppl 2:S4-S9. doi: 10.21101/cejph.a4954.

8.

A Community-Based Study to Estimate the Seroprevalence of Trichinellosis and Echinococcosis in the Roma and Non-Roma Population of Slovakia.

Antolová D, Halánová M, Janičko M, Jarčuška P, Reiterová K, Jarošová J, Madarasová Gecková A, Pella D, Dražilová S; HepaMeta Team.

Int J Environ Res Public Health. 2018 Feb 2;15(2). pii: E251. doi: 10.3390/ijerph15020251.

9.

Pleiotropic effects of statins in the diseases of the liver.

Janicko M, Drazilova S, Pella D, Fedacko J, Jarcuska P.

World J Gastroenterol. 2016 Jul 21;22(27):6201-13. doi: 10.3748/wjg.v22.i27.6201. Review.

10.

Evaluation of hepatic fibrosis - access to non-invasive methods, national practice/guidelines in Central Europe.

Jarcuska P, Bruha R, Horvath G, Simon K, Drazilova S.

Clin Exp Hepatol. 2016 Mar;2(1):12-15. doi: 10.5114/ceh.2016.58851. Epub 2016 Mar 24. Review.

11.

Lower Viral Response to Pegylated Interferon Alpha 2a Treatment of Chronic Hepatitis B in Roma People in Eastern Slovakia.

Drazilova S, Janicko M, Kristian P, Schreter I, Kucinsky B, Kozlej M, Hockickova I, Jarcuska P.

Gastroenterol Res Pract. 2016;2016:8682494. doi: 10.1155/2016/8682494. Epub 2015 Dec 29.

12.

Association between hepatitis B and metabolic syndrome: Current state of the art.

Jarcuska P, Drazilova S, Fedacko J, Pella D, Janicko M.

World J Gastroenterol. 2016 Jan 7;22(1):155-64. doi: 10.3748/wjg.v22.i1.155. Review.

13.

Differences between Roma and non-Roma in how social support from family and friends helps to overcome health care accessibility problems.

Bobakova D, Dankulincova Veselska Z, Babinska I, Klein D, Madarasova Geckova A, Cislakova L; HEPA-META team.

Int J Equity Health. 2015 Apr 14;14:37. doi: 10.1186/s12939-015-0165-z.

14.

Redefining the alanine aminotransferase upper limit of normal improves the prediction of metabolic syndrome risk.

Janičko M, Veselíny E, Orenčák R, Husťak R, Fedačko J, Dražilová S, Madarasová-Gecková A, Mareková M, Pella D, Kristián P, Rác M, Jarčuška P; HepaMeta Study Group.

Eur J Gastroenterol Hepatol. 2015 Apr;27(4):405-11. doi: 10.1097/MEG.0000000000000297.

PMID:
25874513
15.

Seroprevalence of human Toxocara infections in the Roma and non-Roma populations of Eastern Slovakia: a cross-sectional study.

Antolová D, Jarčuška P, Janičko M, Madarasová-Gecková A, Halánová M, Čisláková L, Kalinová Z, Reiterová K, Škutová M, Pella D, Mareková M; HepaMeta Team.

Epidemiol Infect. 2015 Jul;143(10):2249-58. doi: 10.1017/S0950268814003665. Epub 2015 Jan 16.

PMID:
25592864
16.

Clinical and biochemical determinants of metabolic syndrome among Roma and non-Roma subjects in the eastern part of Slovakia.

Fedacko J, Pella D, Jarcuska P, Siegfried L, Janicko M, Veselíny E, Sabol F, Jarcuska P, Mareková M, Gecková AM, Pazinka P, Jankajová M, Kmec J, Babcák M, Kalanin P, Drazilová S; HepaMeta Team.

Cent Eur J Public Health. 2014 Mar;22 Suppl:S75-80.

17.

Prevalence of cardiovascular risk factors in relation to metabolic syndrome in the Roma population compared with the non-Roma population in the eastern part of Slovakia.

Fedacko J, Pella D, Jarcuska P, Siegfried L, Janicko M, Veselíny E, Pella J, Sabol F, Jarcuska P, Mareková M, Gecková AM, Pazinka P, Jankajová M, Kmec J, Babcák M, Kalanin P, Drazilová S, Babinská I, Cecetková B; HepaMeta Team.

Cent Eur J Public Health. 2014 Mar;22 Suppl:S69-74.

18.

Do eating habits of the population living in Roma settlements differ from those of the majority population in Slovakia?

Hijová E, Gecková AM, Babinská I; HepaMeta Team.

Cent Eur J Public Health. 2014 Mar;22 Suppl:S65-8.

19.

Socioeconomic characteristics of the population living in Roma settlements and their association with health and health-related behaviour.

Gecková AM, Babinská I, Bobáková D, Veselská ZD, Bosáková L, Kolarcik P, Jarcuska P, Pella D, Halánová M; HepaMeta Team.

Cent Eur J Public Health. 2014 Mar;22 Suppl:S57-64.

20.

High hepatitis B and low hepatitis C prevalence in Roma population in eastern Slovakia.

Veselíny E, Janicko M, Drazilová S, Siegfried L, Pastvová L, Schréter I, Kristian P, Viág L, Jarcuska P, Valková I, Cáriková K, Senajová G, Fedacko J, Pella D, Mareková M, Gecková AM, Jarcuska P; HepaMeta Team.

Cent Eur J Public Health. 2014 Mar;22 Suppl:S51-6.

Supplemental Content

Loading ...
Support Center